Biocon Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is SACUBITRIL SODIUM, with a corresponding US DMF Number 33426.
Remarkably, this DMF maintains an Active status since its submission on April 26, 2019, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 24, 2019, and payment made on February 08, 2019, indicating their dedication to facilitating drug approvals, Categorized as Type II